Beyond Air, Inc. Net Change in Cash
Beyond Air, Inc. (XAIR) reported Net Change in Cash of -$1.45 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-13
- Beyond Air, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-06-30 was -$1.45M, a 695.88% decline year-over-year.
- Beyond Air, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-06-30 was $243.00K.
- Beyond Air, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-06-30 was -$7.22M.
- Beyond Air, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-06-30 was -$5.20M.
- Beyond Air, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2026 was $7.47M.
- Beyond Air, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was -$6.71M.
- Beyond Air, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$25.16M.
- Beyond Air, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$50.94M, a 192.69% decline from fiscal 2022.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.45M 10-Q · filed 2026-08-13 | |||||||
| 2026-03-31 | $7.47M 10-K · filed 2026-06-26 | |||||||
| 2025-12-31 | $7.93M 10-Q · filed 2026-02-13 | |||||||
| 2025-09-30 | $4.97M 10-Q · filed 2025-11-10 | |||||||
| 2025-06-30 | $243.00K 10-Q · filed 2026-08-13 | |||||||
| 2025-03-31 | -$6.71M 10-K · filed 2026-06-26 | |||||||
| 2024-12-31 | -$6.78M 10-Q · filed 2026-02-13 | |||||||
| 2024-09-30 | $17.07M 10-Q · filed 2025-11-10 | |||||||
| 2024-06-30 | -$7.22M 10-Q · filed 2025-08-12 | |||||||
| 2024-03-31 | -$25.16M 10-K · filed 2025-06-20 | |||||||
| 2023-12-31 | -$28.57M 10-Q · filed 2025-02-10 | |||||||
| 2023-09-30 | -$20.88M 10-Q · filed 2024-11-12 | |||||||
| 2023-06-30 | -$5.20M 10-Q · filed 2024-08-06 | |||||||
| 2023-03-31 | -$50.94M 10-K · filed 2024-06-24 | |||||||
| 2022-12-31 | -$54.67M 10-Q · filed 2024-02-12 | |||||||
| 2022-09-30 | -$50.30M 10-Q · filed 2023-11-13 | |||||||
| 2022-06-30 | -$7.47M 10-Q · filed 2023-08-10 | |||||||
| 2022-03-31 | $54.96M 10-K · filed 2023-06-22 | |||||||
| 2021-12-31 | $57.44M 10-Q · filed 2023-02-10 | |||||||
| 2021-09-30 | $13.48M 10-Q · filed 2022-11-08 | |||||||
| 2021-06-30 | $4.36M 10-Q · filed 2022-08-11 | $4.36M 10-Q · filed 2021-08-10 | ||||||
| 2021-03-31 | $9.80M 10-K · filed 2022-06-29 | $9.80M 10-K · filed 2021-06-10 | ||||||
| 2020-12-31 | -$2.81M 10-Q · filed 2022-02-10 | -$2.81M 10-Q · filed 2021-02-09 | ||||||
| 2020-09-30 | -$3.11M 10-Q · filed 2021-11-12 | -$3.11M 10-Q · filed 2020-11-12 | ||||||
| 2020-06-30 | -$1.02M 10-Q · filed 2021-08-10 | |||||||
| 2020-03-31 | $24.11M 10-K · filed 2021-06-10 | |||||||
| 2019-12-31 | $1.42M 10-Q · filed 2021-02-09 | |||||||
| 2019-09-30 | $997.49K 10-Q · filed 2020-11-12 | |||||||
| 2019-06-30 | -$704.12K 10-Q · filed 2020-08-06 | |||||||
| 2019-03-31 | $618.90K 10-K · filed 2020-06-23 | |||||||
| 2018-12-31 | -$242.62K 10-Q · filed 2020-02-07 | |||||||
| 2018-09-30 | -$406.90K 10-Q · filed 2019-11-06 | -$406.00K 10-Q · filed 2018-11-14 | ||||||
| 2018-06-30 | -$337.09K 10-Q · filed 2019-08-14 | -$337.00K 10-Q · filed 2018-08-14 | ||||||
| 2018-03-31 | -$469.11K 10-K · filed 2019-06-28 | -$468.00K 10-KT · filed 2018-06-15 | -$6.40M 10-K · filed 2019-06-28 | |||||
| 2017-12-31 | -$5.93M 10-Q · filed 2019-02-14 | $1.20M 10-K · filed 2019-06-28 | $1.12M 10-KT · filed 2018-06-15 | |||||
| 2017-09-30 | -$5.39M 10-Q · filed 2018-11-14 | |||||||
| 2017-06-30 | -$1.95M 10-Q · filed 2018-08-14 | |||||||
| 2017-03-31 | $7.13M 10-K · filed 2019-06-28 | $7.13M 10-KT · filed 2018-06-15 | ||||||
| 2016-12-31 | -$122.00K 10-KT · filed 2018-06-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |